Triumeq is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Abacavir Sulfate; Dolutegravir Sodium; Lamivudine.
| Product ID | 50090-1606_37a43c59-6382-40e8-9a5b-cc9d0e01122d |
| NDC | 50090-1606 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Triumeq |
| Generic Name | Abacavir Sulfate, Dolutegravir Sodium, Lamivudine |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-08-22 |
| Marketing Category | NDA / NDA |
| Application Number | NDA205551 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE |
| Active Ingredient Strength | 600 mg/1; mg/1; mg/1 |
| Pharm Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2015-01-07 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA205551 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-01-07 |
| Marketing End Date | 2019-03-31 |
| Ingredient | Strength |
|---|---|
| ABACAVIR SULFATE | 600 mg/1 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 49702-231 | Triumeq | abacavir sulfate, dolutegravir sodium, lamivudine |
| 50090-1606 | Triumeq | abacavir sulfate, dolutegravir sodium, lamivudine |
| 49702-258 | Triumeq PD | abacavir sulfate, dolutegravir sodium, lamivudine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TRIUMEQ 77650550 4000175 Live/Registered |
VIIV HEALTHCARE COMPANY 2009-01-15 |